Latham & Watkins LLP represented the underwriters in the offering. Mirum Pharmaceuticals, Inc, a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
